Related Experiment Videos
[Antibiotic prophylaxis with sulbactam/ampicillin in colon surgery]
D Gui1, G Anastasio, M Pescatori
1Università Cattolica del Sacro Cuore, Roma Instituto di Clinica Chirurgica.
Minerva Chirurgica
|April 15, 1990
Summary
Sulbactam/ampicillin effectively prevents surgical site infections in elective colic surgery. This antibiotic regimen demonstrated good tolerability and a low infection rate in the study group.
Area of Science:
- Surgical prophylaxis
- Infectious disease
- Pharmacology
Background:
- Surgical site infections (SSIs) are a significant concern in colorectal surgery.
- Perioperative antibiotic prophylaxis is crucial for reducing SSI rates.
- Evaluating established antibiotic regimens ensures optimal patient outcomes.
Purpose of the Study:
- To assess the efficacy of sulbactam/ampicillin as a perioperative prophylactic agent.
- To determine the safety and tolerability of this regimen in patients undergoing elective colic surgery.
- To evaluate the incidence of surgical site infections with sulbactam/ampicillin prophylaxis.
Main Methods:
- An open, non-comparative trial involving 18 patients undergoing elective colic surgery.
- Sulbactam/ampicillin (S/A) administered pre-operatively and repeated every 6 hours for up to 5 doses.
- Monitoring for adverse events and recording infection rates.
Main Results:
- The sulbactam/ampicillin regimen was well tolerated by all patients.
- No side effects necessitated the interruption of antibiotic prophylaxis.
- A low infection rate was observed, with only one case of wound suppuration.
Conclusions:
- Sulbactam/ampicillin serves as an effective and safe perioperative prophylaxis for elective colic surgery.
- The observed low infection rate supports the use of this regimen in similar surgical procedures.
- Further large-scale studies could solidify these findings in diverse patient populations.